The management of residual masses after chemotherapy in metastatic seminoma

BJU International

Volumn 83, Issue 6, 1999, Pages 649-653

  Ravi, R ^a   Ong, J ^a   Oliver, R T D ^a   Badenoch, D F ^a   Fowler, C G ^a   Hendry, W F ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Residual mass; Response; Seminoma; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN;

ARTICLE; CANCER STATISTICS; COMPUTER ASSISTED TOMOGRAPHY; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; RADIODIAGNOSIS; SEMINOMA;

HUMANS; MALE; NEOPLASM, RESIDUAL; SEMINOMA; TESTICULAR NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032956255     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00974.x     Document Type: Article

References (26)

1. 1 Oliver RTD, Hope-Stone HF, Blandy JP. Possible new approaches to the management of seminoma of the testes. Br J Urol 1984; 56: 729-33
2. 2 Oliver RTD, Love S, Ong J. Alternatives to radiotherapy in the management of seminoma. Br J Urol 1990; 65: 61-7
3. 3 Horwich A, Dearnaley DP, A'hern R et al. The activity of single-agent carboplatin in advanced seminoma. Eur J Cancer 1992; 28A: 1307-10
4. 4 Oliver RTD, Ong J. Seventeen years experience of phase I/II studies of single-agent platinum compounds as alternatives to radiation for metastatic and stage I seminoma. Proc Amer Soc Clin Oncol 1996; 15: A613, 244
5. 5 Einhorn LH, Williams SD. Chemotherapy of disseminated seminoma. Cancer Clin Trials 1980; 3: 307-13
6. 6 Puc HS, Heelan R, Mazumdar M et al. Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center. J Clin Oncol 1996; 14: 454-60
7. 7 Herr HW, Sheinfield J, Puc HS et al. Surgery for a postchemotherapy residual mass in seminoma. J Urol 1997; 157: 860-2
8. 8 Horwich A, Paluchowska B, Norman A et al. Residual mass following chemotherapy of seminoma. Ann Oncol 1997; 8: 37-40
9. 9 Loehrer PJ, Birch R, Williams SD, Greco FA, Einhorn LH. Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience. J Clin Oncol 1987; 5: 1212-20
10. 10 Motzer R, Bosl G, Heelan R et al. Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J Clin Oncol 1987; 5: 1064-70
11. 11 Motzer RJ, Bosl G, Geller NL et al. Advanced seminoma: the role of chemotherapy and adjunctive surgery. Ann Intern Med 1988; 108: 513-8
12. 12 Friedman EL, Garnick MB, Stomper PC, Mauch PM, Harrington DP, Richie JP. Therapeutic guidelines and results in advanced seminoma. J Clin Oncol 1985; 3: 1325-32
13. 13 Carter GE, Leiskowsky G, Skinner DG, Daniels JR. Reassessment of the role of adjunctive surgical resection in the treatment of advanced germ cell tumors. J Urol 1987; 138: 1397-401
14. 14 Schultz SM, Einhorn LH, Conces DJ Jr, Williams SD, Loehrer PJ. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol 1989; 7: 1497-503
15. 15 Huben RP, Pontes JE. Advances in the treatment of testicular tumors. Int Adv Surg Oncol 1984; 7: 355-72
16. 16 Peckham MJ, Horwich A, Hendry WF. Advanced seminoma: treatment with cisplatinum-based combination chemotherapy or carboplatin (JM8). Br J Cancer 1985; 52: 7-13
17. 17 Fossa SD, Kullmann G, Lien HH, Stenwig AE, Ous S. Chemotherapy of advanced seminoma: clinical significance of radiological findings before and after treatment. Br J Urol 1989; 64: 530-4
18. 18 Crawford ED, Goodman P, Nabors WL et al. Treatment of stages B3 and C seminoma with chemotherapy followed by irradiation therapy. Southwest Oncology Group Study. Urology 1992; 39: 457-60
19. 19 Herr HW, Bosl G. Residual mass after chemotherapy for seminoma: changing concepts of management. J Urol 1987; 137: 1234-5
20. 20 Ellison MF, Mostofi FK, Flanigan RC. Treatment of residual retroperitoneal mass after chemotherapy for advanced seminoma. J Urol 1988; 140: 618-20
21. 21 Kamat MR, Kulkarni JN, Tongaonkar HB, Ravi R. Value of retroperitoneal lymph node dissection in advanced testicular seminoma. J Surg Oncol 1992; 51: 65-7
22. 22 Ravi R, Vasanthan A. Intraoperative irradiation: another option for the treatment of ≥ 3cm residual mass following chemotherapy for advanced testicular seminoma. Urol Int 1995; 55: 137-40
23. 23 Bokemeyer C, Schmoll HJ. Treatment of testicular cancer and the development of secondary malignancies. J Clin Oncol 1995; 13: 283-92
24. 24 Fossa SD, Borge L, Aass N, Johannessen NB, Stenwig AE, Kaalhus O. The treatment of advanced metastatic seminoma: experience in 55 cases. J Clin Oncol 1987; 5: 1071-7
25. 25 Weissbach L, Hartlapp JH. Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor. J Urol 1991; 146; 1295-8
26. 26 Duchesne GM, Stenning SP, Aass N et al. Radiotherapy after chemotherapy for metastatic seminoma - a diminishing role. MRC Testicular Tumour Working Party Eur J Cancer 1997; 33: 829-35